Aroa Biosurgery Limited (AROAF)

Market Cap	147.85M +6.7%
Revenue (ttm)	59.34M +22.6%
Net Income	2.67M
EPS	0.01
Shares Out	n/a
PE Ratio	55.31
Forward PE	47.95
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.5200
Previous Close	0.5200
Day's Range	0.5200 - 0.5200
52-Week Range	0.3845 - 0.5220
Beta	0.85
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Aroa Biosurgery

Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; and Myriad Morcells, Myriad Morcells Fine, Myriad Meshed, and Symphony products for the treatment of partial and full-thickness wounds, p...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2007
• Country: New Zealand
• Stock Exchange: OTCMKTS
• Ticker Symbol: AROAF

Financial Performance

Financial numbers in NZD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 11, 2026

Data Sources Report a data error